Clinical and immunologic components of sarcoidosis
Identifieur interne : 002121 ( Main/Exploration ); précédent : 002120; suivant : 002122Clinical and immunologic components of sarcoidosis
Auteurs : Andrea T. Borchers [États-Unis] ; Calvin So [États-Unis] ; Stanley M. Naguwa [États-Unis] ; Carl L. Keen [États-Unis] ; M. Eric Gershwin [États-Unis]Source :
- Clinical Reviews in Allergy & Immunology [ 1080-0549 ] ; 2003-12-01.
English descriptors
- KwdEn :
Abstract
Abstract: Sarcoidosis is a multisystem granulomatous disease of unknown etiology that affects the lungs and the lymphatic system. It is seen by specialists in allergy, rheumatology, and pulmonary disease. Although there are no clues to etiology, an environmental basis has been implicated primarily on the basis of epidemiologic and anecdotal data. The majority of patients are very readily diagnosed and should not be confused with other pulmonary disorders. Sarcoidosis can become an issue if it occurs in the presence of other significant pulmonary disease, such as patients with asthma or hypersensitivity pneumonitis. Most patients remain asymptomatic and many are diagnosed when picked up on a routine screenign exam. Steroids can be used to manage some patients but caution should be exercised to choose the appropriate dose and to treat patients for a limited period of time to avoid the complications of steroids. A minority of patients do progress to significant disease, including morbidity and mortality, and further research is needed to determine more appropriate and specific therapy for such situations.
Url:
DOI: 10.1385/CRIAI:25:3:289
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000514
- to stream Istex, to step Curation: 000514
- to stream Istex, to step Checkpoint: 000F57
- to stream Main, to step Merge: 002140
- to stream Main, to step Curation: 002121
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Clinical and immunologic components of sarcoidosis</title><author><name sortKey="Borchers, Andrea T" sort="Borchers, Andrea T" uniqKey="Borchers A" first="Andrea T." last="Borchers">Andrea T. Borchers</name></author><author><name sortKey="So, Calvin" sort="So, Calvin" uniqKey="So C" first="Calvin" last="So">Calvin So</name></author><author><name sortKey="Naguwa, Stanley M" sort="Naguwa, Stanley M" uniqKey="Naguwa S" first="Stanley M." last="Naguwa">Stanley M. Naguwa</name></author><author><name sortKey="Keen, Carl L" sort="Keen, Carl L" uniqKey="Keen C" first="Carl L." last="Keen">Carl L. Keen</name></author><author><name sortKey="Gershwin, M Eric" sort="Gershwin, M Eric" uniqKey="Gershwin M" first="M. Eric" last="Gershwin">M. Eric Gershwin</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:FFA3830048E7901FF7BF5D27D82DA6A9A53E14B9</idno><date when="2003" year="2003">2003</date><idno type="doi">10.1385/CRIAI:25:3:289</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-GJZ3N37H-X/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000514</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000514</idno><idno type="wicri:Area/Istex/Curation">000514</idno><idno type="wicri:Area/Istex/Checkpoint">000F57</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000F57</idno><idno type="wicri:doubleKey">1080-0549:2003:Borchers A:clinical:and:immunologic</idno><idno type="wicri:Area/Main/Merge">002140</idno><idno type="wicri:Area/Main/Curation">002121</idno><idno type="wicri:Area/Main/Exploration">002121</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Clinical and immunologic components of sarcoidosis</title><author><name sortKey="Borchers, Andrea T" sort="Borchers, Andrea T" uniqKey="Borchers A" first="Andrea T." last="Borchers">Andrea T. Borchers</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Division of Rheumatology, Allergy, and Clinical Immunology, University of California at Davis, 95616, Davis</wicri:cityArea></affiliation></author><author><name sortKey="So, Calvin" sort="So, Calvin" uniqKey="So C" first="Calvin" last="So">Calvin So</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Division of Rheumatology, Allergy, and Clinical Immunology, University of California at Davis, 95616, Davis</wicri:cityArea></affiliation></author><author><name sortKey="Naguwa, Stanley M" sort="Naguwa, Stanley M" uniqKey="Naguwa S" first="Stanley M." last="Naguwa">Stanley M. Naguwa</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Division of Rheumatology, Allergy, and Clinical Immunology, University of California at Davis, 95616, Davis</wicri:cityArea></affiliation></author><author><name sortKey="Keen, Carl L" sort="Keen, Carl L" uniqKey="Keen C" first="Carl L." last="Keen">Carl L. Keen</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Department of Nutrition, University of California at Davis, 95616, Davis</wicri:cityArea></affiliation></author><author><name sortKey="Gershwin, M Eric" sort="Gershwin, M Eric" uniqKey="Gershwin M" first="M. Eric" last="Gershwin">M. Eric Gershwin</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Division of Rheumatology, Allergy, and Clinical Immunology, University of California at Davis, 95616, Davis</wicri:cityArea></affiliation><affiliation wicri:level="1"><country wicri:rule="url">États-Unis</country></affiliation></author></analytic><monogr></monogr><series><title level="j">Clinical Reviews in Allergy & Immunology</title><title level="j" type="abbrev">Clinic Rev Allerg Immunol</title><idno type="ISSN">1080-0549</idno><idno type="eISSN">1559-0267</idno><imprint><publisher>Humana Press</publisher><pubPlace>Totowa</pubPlace><date type="published" when="2003-12-01">2003-12-01</date><biblScope unit="volume">25</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="289">289</biblScope><biblScope unit="page" to="303">303</biblScope></imprint><idno type="ISSN">1080-0549</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1080-0549</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Granulomatous disease</term><term>immune response</term><term>steroids</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Sarcoidosis is a multisystem granulomatous disease of unknown etiology that affects the lungs and the lymphatic system. It is seen by specialists in allergy, rheumatology, and pulmonary disease. Although there are no clues to etiology, an environmental basis has been implicated primarily on the basis of epidemiologic and anecdotal data. The majority of patients are very readily diagnosed and should not be confused with other pulmonary disorders. Sarcoidosis can become an issue if it occurs in the presence of other significant pulmonary disease, such as patients with asthma or hypersensitivity pneumonitis. Most patients remain asymptomatic and many are diagnosed when picked up on a routine screenign exam. Steroids can be used to manage some patients but caution should be exercised to choose the appropriate dose and to treat patients for a limited period of time to avoid the complications of steroids. A minority of patients do progress to significant disease, including morbidity and mortality, and further research is needed to determine more appropriate and specific therapy for such situations.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Californie</li></region></list><tree><country name="États-Unis"><region name="Californie"><name sortKey="Borchers, Andrea T" sort="Borchers, Andrea T" uniqKey="Borchers A" first="Andrea T." last="Borchers">Andrea T. Borchers</name></region><name sortKey="Gershwin, M Eric" sort="Gershwin, M Eric" uniqKey="Gershwin M" first="M. Eric" last="Gershwin">M. Eric Gershwin</name><name sortKey="Gershwin, M Eric" sort="Gershwin, M Eric" uniqKey="Gershwin M" first="M. Eric" last="Gershwin">M. Eric Gershwin</name><name sortKey="Keen, Carl L" sort="Keen, Carl L" uniqKey="Keen C" first="Carl L." last="Keen">Carl L. Keen</name><name sortKey="Naguwa, Stanley M" sort="Naguwa, Stanley M" uniqKey="Naguwa S" first="Stanley M." last="Naguwa">Stanley M. Naguwa</name><name sortKey="So, Calvin" sort="So, Calvin" uniqKey="So C" first="Calvin" last="So">Calvin So</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002121 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002121 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:FFA3830048E7901FF7BF5D27D82DA6A9A53E14B9
|texte= Clinical and immunologic components of sarcoidosis
}}
| This area was generated with Dilib version V0.6.33. |  |